Delivery Order SPE2DB20D1110-SPE2DB25FK34N
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose 30-count supply on July 29, 2025, with completion scheduled for August 19, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies,...
- The Defense Logistics Agency (DLA) awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 MG daily dose (60-count supply) with an ultimate completion date of August 19, 2025. This non-set-aside competitive award was issued on July 29, 2025, with performance to be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, reflecting the federal government's continued reliance on...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 8 mg daily dose in a quantity of 60 units, with a ceiling value of $10,223.24. This firm fixed-price delivery order, issued on August 11, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 10 MG daily dose tablets (30-count supply). This firm fixed-price, non-set-aside contract was awarded on August 18, 2025, with an ultimate completion date of September 9, 2025. LENVIMA (lenvatinib) is a targeted cancer therapy used to treat various malignancies, reflecting the pharmaceutical distributor's role in supplying specialized oncology medications to federal...
- The Defense Logistics Agency awarded a $10,223.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose tablets (30-count package) with an ultimate completion date of August 19, 2025. This non-competitive delivery order was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy indicated for multiple malignancies, and this award reflects...
- The Defense Logistics Agency awarded a $10,223.24 delivery order to AmerisourceBergen Drug Corp for LENVIMA 10 mg daily dose medication (30-count supply) on November 7, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract supports federal medical procurement needs within the military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of LENVIMA 10 mg daily dose in a 30-count package with a ceiling value of $10,223.24. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 25, 2025, and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 18 mg daily dose tablets (90-count supply) valued at $10,223.24 under a firm fixed-price contract type. The award was made on August 8, 2025, with an ultimate completion date of August 29, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this pharmaceutical delivery. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of LENVIMA 14 mg daily dose tablets (60-count packaging) with a contract ceiling value of $10,223.24. This competitive award, issued under a firm fixed price delivery order with no set-aside designation, is scheduled for ultimate completion on September 3, 2025, and will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 8 mg daily dose tablets (60-count units) under a firm fixed-price contract valued at $21,547.44. This competitively awarded, non-set-aside delivery order has an ultimate completion date of November 26, 2025, and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen...
- SPE2DB20D1110Indefinite Delivery Contract
- SPE2DB20D1110-SPE2DB25FK34NDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,223.24 to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose (60-count supply) on August 14, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. LENVIMA is a targeted cancer therapy medication, and this procurement supports the federal government's pharmaceutical supply requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive contracting processes across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/14/25 |